{"url":"https://lda.senate.gov/api/v1/filings/cf1ac1cb-fb8f-4fa2-9f05-ef0b3c060a2f/","filing_uuid":"cf1ac1cb-fb8f-4fa2-9f05-ef0b3c060a2f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cf1ac1cb-fb8f-4fa2-9f05-ef0b3c060a2f/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stephen P. Roberts, Attorney & Agent for Filer","dt_posted":"2026-04-20T22:37:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Milk Street","registrant_address_2":"16th Floor","registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02114","registrant":{"id":401103747,"url":"https://lda.senate.gov/api/v1/registrants/401103747/","house_registrant_id":null,"name":"SACHEM STRATEGIES","description":"Lobbying firm","address_1":"750 Main Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02139","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NATHANIEL WALTON","contact_telephone":"+1 617-780-2252","dt_updated":"2026-07-30T17:42:40.417693-04:00"},"client":{"id":69985,"url":"https://lda.senate.gov/api/v1/clients/69985/","client_id":69985,"name":"STRAND THERAPEUTICS","general_description":"mRNA therapeutics company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-06"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to biomanufacturing policy (no specific legislation).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62270,"prefix":null,"prefix_display":null,"first_name":"NATHANIEL","nickname":null,"middle_name":null,"last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}